Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Positive;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis;   ...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis; &n...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis; &n...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis; &n...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Condition:   Prostate CancerInterventions:   Drug: bicalutamide;   Drug: buserelin;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: prednisone;   Drug: triptorelin;   Radiation: radiation therapySponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI);   NRG OncologyActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2006 Category: Research Source Type: clinical trials

Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Condition:   Prostate CancerIntervention:   Drug: lapatinib ditosylateSponsors:   UNC Lineberger Comprehensive Cancer Center;   National Cancer Institute (NCI)Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2005 Category: Research Source Type: clinical trials

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Condition:   Metastatic Breast CancerIntervention:   Drug: LapatinibSponsors:   Dartmouth-Hitchcock Medical Center;   University of Colorado, Denver;   North Shore University HospitalTerminated - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2005 Category: Research Source Type: clinical trials

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
Conditions:   Prostate Cancer;   Erectile DysfunctionInterventions:   Drug: sildenafil citrate and questionaires;   Drug: placebo tablets and questionairesSponsors:   Memorial Sloan-Kettering Cancer Center;   Memorial Sloan-Kettering Cancer Center;   Mount Sinai School of Medicine;   Beth Israel Medical Center;   St. Luke's-Roosevelt Hospital CenterActive, not recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2005 Category: Research Source Type: clinical trials

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
Conditions:   Prostate Cancer;   Erectile DysfunctionInterventions:   Drug: sildenafil citrate and questionaires;   Drug: placebo tablets and questionairesSponsors:   Memorial Sloan-Kettering Cancer Center;   Mount Sinai School of Medicine;   Beth Israel Medical Center;   St. Luke's-Roosevelt Hospital CenterCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2005 Category: Research Source Type: clinical trials